ArticleJournal of clinical and experimental hepatology2014
Future of therapy for Hepatitis C in India: A Matter of Accessibility and Affordability?
Article in Journal of clinical and experimental hepatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness.Harm reduction journal · 2024Article
- Balancing uncertainty and proactivity in care seeking for hepatitis C: qualitative research with participants enrolled in a treatment trial in Ho Chi Minh City, Vietnam.International journal of qualitative studies on health and well-being · 2022Article
- Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India.Liver international : official journal of the International Association for the Study of the Liver · 2022Article
- Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India.The Indian journal of medical research · 2018Article
- Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?Journal of clinical and experimental hepatology · 2017Review
- Why Should Viral Markers Be Mandatory in Ocular Surgeries: A Hospital Based Retrospective Study.Journal of clinical and diagnostic research : JCDR · 2016Article
- Tackling the Hepatitis C Disease Burden in Punjab, India.Journal of clinical and experimental hepatology · 2016Review
- Combating the wrath of viral hepatitis in India.The Indian journal of medical research · 2016Article
- Cancer incidence among Asian American populations in the United States, 2009-2011.International journal of cancer · 2016Article
- Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C.Journal of postgraduate medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.